476 related articles for article (PubMed ID: 29350055)
1. Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer's disease.
Karthivashan G; Ganesan P; Park SY; Kim JS; Choi DK
Drug Deliv; 2018 Nov; 25(1):307-320. PubMed ID: 29350055
[TBL] [Abstract][Full Text] [Related]
2. Advancements in nanotherapeutics for Alzheimer's disease: current perspectives.
Harilal S; Jose J; Parambi DGT; Kumar R; Mathew GE; Uddin MS; Kim H; Mathew B
J Pharm Pharmacol; 2019 Sep; 71(9):1370-1383. PubMed ID: 31304982
[TBL] [Abstract][Full Text] [Related]
3. Neurotherapeutic applications of nanoparticles in Alzheimer's disease.
Sahni JK; Doggui S; Ali J; Baboota S; Dao L; Ramassamy C
J Control Release; 2011 Jun; 152(2):208-31. PubMed ID: 21134407
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Strategies and Nano-Drug Delivery Applications in Management of Aging Alzheimer's Disease.
Nguyen TT; Vo TK; Vo GV
Adv Exp Med Biol; 2021; 1286():183-198. PubMed ID: 33725354
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's Disease Targeted Nano-Based Drug Delivery Systems.
Altinoglu G; Adali T
Curr Drug Targets; 2020; 21(7):628-646. PubMed ID: 31744447
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease.
Fonseca-Santos B; Gremião MP; Chorilli M
Int J Nanomedicine; 2015; 10():4981-5003. PubMed ID: 26345528
[TBL] [Abstract][Full Text] [Related]
7. Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations.
Zorkina Y; Abramova O; Ushakova V; Morozova A; Zubkov E; Valikhov M; Melnikov P; Majouga A; Chekhonin V
Molecules; 2020 Nov; 25(22):. PubMed ID: 33202839
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease and its treatment by different approaches: A review.
Srivastava S; Ahmad R; Khare SK
Eur J Med Chem; 2021 Apr; 216():113320. PubMed ID: 33652356
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in Targeted Drug Delivery Approaches Using Lipidic and Polymeric Nanocarriers for the Management of Alzheimer's Disease.
Jain D; Rashid MA; Ahmad FJ
Curr Pharm Des; 2021; 27(43):4388-4403. PubMed ID: 34579627
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicine: A New Frontier in Alzheimer's Disease Drug Targeting.
Pathak K; Ahmad MZ; Saikia R; Pathak MP; Sahariah JJ; Kalita P; Das A; Islam MA; Pramanik P; Tayeng D; Abdel-Wahab BA
Cent Nerv Syst Agents Med Chem; 2024 Mar; ():. PubMed ID: 38551038
[TBL] [Abstract][Full Text] [Related]
11. Reassembly of native components with donepezil to execute dual-missions in Alzheimer's disease therapy.
Zhang H; Zhao Y; Yu M; Zhao Z; Liu P; Cheng H; Ji Y; Jin Y; Sun B; Zhou J; Ding Y
J Control Release; 2019 Feb; 296():14-28. PubMed ID: 30639387
[TBL] [Abstract][Full Text] [Related]
12. Nanotechnological strategies for nerve growth factor delivery: Therapeutic implications in Alzheimer's disease.
Faustino C; Rijo P; Reis CP
Pharmacol Res; 2017 Jun; 120():68-87. PubMed ID: 28351757
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional Nanocarriers for Alzheimer's Disease: Befriending the Barriers.
Ansari MA; Tripathi T; Venkidasamy B; Monziani A; Rajakumar G; Alomary MN; Alyahya SA; Onimus O; D'souza N; Barkat MA; Al-Suhaimi EA; Samynathan R; Thiruvengadam M
Mol Neurobiol; 2024 May; 61(5):3042-3089. PubMed ID: 37966683
[TBL] [Abstract][Full Text] [Related]
14. Nanotechnology-based Drug Delivery for Alzheimer's and Parkinson's Diseases.
Nguyen-Thi PT; Ho TT; Nguyen TT; Vo GV
Curr Drug Deliv; 2024; 21(7):917-931. PubMed ID: 37424345
[TBL] [Abstract][Full Text] [Related]
15. Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease.
Wilson B; Samanta MK; Santhi K; Kumar KP; Paramakrishnan N; Suresh B
Brain Res; 2008 Mar; 1200():159-68. PubMed ID: 18291351
[TBL] [Abstract][Full Text] [Related]
16. Potential Neuroprotective Strategies using Smart Drug Delivery Systems for Alzheimer's Disease.
Khan J; Yadav S; Alam MA
Infect Disord Drug Targets; 2024; 24(3):e231023222565. PubMed ID: 37873911
[TBL] [Abstract][Full Text] [Related]
17. Microbial acetylcholinesterase inhibitors for Alzheimer's therapy: recent trends on extraction, detection, irradiation-assisted production improvement and nano-structured drug delivery.
Zaki AG; El-Sayed ER; Abd Elkodous M; El-Sayyad GS
Appl Microbiol Biotechnol; 2020 Jun; 104(11):4717-4735. PubMed ID: 32285176
[TBL] [Abstract][Full Text] [Related]
18. Intranasal Lipid Particulate Drug Delivery Systems: An Update on Clinical Challenges and Biodistribution Studies of Cerebroactive Drugs in Alzheimer's disease.
Arora D; Bhatt S; Kumar M; Vattikonda HDC; Taneja Y; Jain V; Joshi V; Gali CC
Curr Pharm Des; 2020; 26(27):3281-3299. PubMed ID: 32228421
[TBL] [Abstract][Full Text] [Related]
19. Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases.
Masoudi Asil S; Ahlawat J; Guillama Barroso G; Narayan M
Biomater Sci; 2020 Aug; 8(15):4109-4128. PubMed ID: 32638706
[TBL] [Abstract][Full Text] [Related]
20. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
